Skip to main content
Home
BE
  • nl
  • fr
  • en
  • Get to know Sciensano
    • About Sciensano
    • Sciensano in figures
    • Sciensano's structure
    • Contact Sciensano
    • Our commitment to quality, health, safety and environment
    • Our commitment to collecting and managing data
    • Partnerships
    • Emergency and Response
    • Working / doing an internship at Sciensano
    • Jobs
    • Values and standards
    • History of Sciensano
    • 2024 Annual report
    • Donations and bequests
  • Areas of expertise
    • List of health topics from A-Z
    • Health and disease monitoring
    • Animal Health
    • Effectiveness of safety of vaccines, medicines and health products - Quality of medical laboratories
    • Food consumption and food safety
    • Health and environment
    • Quality of healthcare
  • Our services
    • Analysis request
    • Data collection
    • External quality assessment
    • Control and Safety Assessment
    • Licensing
    • Health Information
    • Health Threats
    • Projects
    • Reports & Publications
  • Press Corner

Search form

  1. Home
  2. Biblio
  3. Potential business model for a European vaccine R&D infrastructure and its estimated socio-economic impact

Potential business model for a European vaccine R&D infrastructure and its estimated socio-economic impact

Last updated on 16-11-2023 by Alexandre Dobly
Effectiveness and safety of vaccines, medicines and health products - Quality of medical laboratories  
Download 1006.78 KB

Public Access

Published

Peer reviewed scientific article

English

DOI : https://doi.org/10.12688/f1000research.141399.1

Authors

Stefan Jungbluth; William Martin; Monika Slezak; Hilde Depraetere; Carlos A. Guzman; Anton Ussi; David Morrow; Fran Van Heuverswyn; Sven Arnouts; Manuel J. T. Carrondo; Ole Olesen; Tom H.M. Ottenhoff; H. M. Dockrell; Mei Mei Ho; Alexandre Dobly; Dennis Christensen; Joaquim Segalés; Fabrice Laurent; Frédéric Lantier; Norbert Stockhofe-Zurwieden; Francesca Morelli; Jan A.M. Langermans; Frank A.W. Verreck; Roger Le Grand; Arjen Sloots; Donata Medaglini; Maria Lawrenz; Nicolas Collin

Keywords

    Associated health topics:

    Effectiveness and safety of vaccines, medicines and health products - Quality of medical laboratories
    • DOI
    • RTF
    • Tagged
    • EndNote XML
    • RIS

    QR code

    QR code for this page URL
    Printer-friendly version

    Sciensano info

     +32 2 642 51 11
     info@sciensano.be
     contact
     +32 2 642 50 01

    Postal address

    Sciensano
    Rue Juliette Wytsmanstraat 14
    1050 Brussels, Belgium

    About us
    Sciensano jobs
    Responsibility and privacy
    Privacy notice
    Accessibility statement
    Privacy Settings

    Sciensano Logo